| Dr Jon P Filardi, MD | |
|
3705 Medical Pkwy, Suite 570, Austin, TX 78705 | |
| (512) 454-2454 | |
| (512) 454-1532 |
| Full Name | Dr Jon P Filardi |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 40 Years |
| Location | 3705 Medical Pkwy, Austin, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295716652 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | G8105 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension Seton Medical Center Austin | Austin, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| U S Anesthesia Partners Of Texas, Pa | 7315850351 | 2379 |
News Archive
Vocera Communications, Inc., the leading provider of integrated, intelligent communication solutions for mission-critical environments in healthcare, hospitality, energy, retail and other mobile work environments, today announced that a preview of its innovative Vocera Collaboration Suite will be shown at the ANCC National Magnet Conference® beginning today.
A candidate Ebola vaccine could be given to healthy volunteers in the UK, The Gambia and Mali as early as September, as part of an series of safety trials of potential vaccines aimed at preventing the disease that has killed more than 1,400 people in the current outbreak in West Africa.
Long the domain of philosophy and religion, free will has also been defined by scientists as a combination of two cognitive processes - the desire to act (or volition) and the sense of responsibility for our actions (or agency.)
Targeted cancer cell therapies using man-made proteins dramatically shrink many tumors in the first few months of treatment, but new research from Johns Hopkins scientists finds why the cells all too often become resistant, the treatment stops working, and the disease returns.
Cequent Pharmaceuticals, a pioneer in the development of novel products to deliver RNAi-based treatments to prevent and treat human disease, announced that Chief Executive Officer, Peter Parker, will provide details on Cequent's planned launch of its clinical program and highlight strategy and development goals in a company update scheduled for 3 p.m. on Tuesday, October 27, 2009, at the 2009 BIOCOM Investor Conference.
› Verified 5 days ago
| Entity Name | U S Anesthesia Partners Of Texas, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548208564 PECOS PAC ID: 7315850351 Enrollment ID: O20031106000563 |
News Archive
Vocera Communications, Inc., the leading provider of integrated, intelligent communication solutions for mission-critical environments in healthcare, hospitality, energy, retail and other mobile work environments, today announced that a preview of its innovative Vocera Collaboration Suite will be shown at the ANCC National Magnet Conference® beginning today.
A candidate Ebola vaccine could be given to healthy volunteers in the UK, The Gambia and Mali as early as September, as part of an series of safety trials of potential vaccines aimed at preventing the disease that has killed more than 1,400 people in the current outbreak in West Africa.
Long the domain of philosophy and religion, free will has also been defined by scientists as a combination of two cognitive processes - the desire to act (or volition) and the sense of responsibility for our actions (or agency.)
Targeted cancer cell therapies using man-made proteins dramatically shrink many tumors in the first few months of treatment, but new research from Johns Hopkins scientists finds why the cells all too often become resistant, the treatment stops working, and the disease returns.
Cequent Pharmaceuticals, a pioneer in the development of novel products to deliver RNAi-based treatments to prevent and treat human disease, announced that Chief Executive Officer, Peter Parker, will provide details on Cequent's planned launch of its clinical program and highlight strategy and development goals in a company update scheduled for 3 p.m. on Tuesday, October 27, 2009, at the 2009 BIOCOM Investor Conference.
› Verified 5 days ago
| Entity Name | Seton Family Of Doctors |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588997233 PECOS PAC ID: 0941333280 Enrollment ID: O20100806000260 |
News Archive
Vocera Communications, Inc., the leading provider of integrated, intelligent communication solutions for mission-critical environments in healthcare, hospitality, energy, retail and other mobile work environments, today announced that a preview of its innovative Vocera Collaboration Suite will be shown at the ANCC National Magnet Conference® beginning today.
A candidate Ebola vaccine could be given to healthy volunteers in the UK, The Gambia and Mali as early as September, as part of an series of safety trials of potential vaccines aimed at preventing the disease that has killed more than 1,400 people in the current outbreak in West Africa.
Long the domain of philosophy and religion, free will has also been defined by scientists as a combination of two cognitive processes - the desire to act (or volition) and the sense of responsibility for our actions (or agency.)
Targeted cancer cell therapies using man-made proteins dramatically shrink many tumors in the first few months of treatment, but new research from Johns Hopkins scientists finds why the cells all too often become resistant, the treatment stops working, and the disease returns.
Cequent Pharmaceuticals, a pioneer in the development of novel products to deliver RNAi-based treatments to prevent and treat human disease, announced that Chief Executive Officer, Peter Parker, will provide details on Cequent's planned launch of its clinical program and highlight strategy and development goals in a company update scheduled for 3 p.m. on Tuesday, October 27, 2009, at the 2009 BIOCOM Investor Conference.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jon P Filardi, MD Po Box 840853, Dallas, TX 75284-0853 Ph: (972) 233-1999 | Dr Jon P Filardi, MD 3705 Medical Pkwy, Suite 570, Austin, TX 78705 Ph: (512) 454-2454 |
News Archive
Vocera Communications, Inc., the leading provider of integrated, intelligent communication solutions for mission-critical environments in healthcare, hospitality, energy, retail and other mobile work environments, today announced that a preview of its innovative Vocera Collaboration Suite will be shown at the ANCC National Magnet Conference® beginning today.
A candidate Ebola vaccine could be given to healthy volunteers in the UK, The Gambia and Mali as early as September, as part of an series of safety trials of potential vaccines aimed at preventing the disease that has killed more than 1,400 people in the current outbreak in West Africa.
Long the domain of philosophy and religion, free will has also been defined by scientists as a combination of two cognitive processes - the desire to act (or volition) and the sense of responsibility for our actions (or agency.)
Targeted cancer cell therapies using man-made proteins dramatically shrink many tumors in the first few months of treatment, but new research from Johns Hopkins scientists finds why the cells all too often become resistant, the treatment stops working, and the disease returns.
Cequent Pharmaceuticals, a pioneer in the development of novel products to deliver RNAi-based treatments to prevent and treat human disease, announced that Chief Executive Officer, Peter Parker, will provide details on Cequent's planned launch of its clinical program and highlight strategy and development goals in a company update scheduled for 3 p.m. on Tuesday, October 27, 2009, at the 2009 BIOCOM Investor Conference.
› Verified 5 days ago
Dr. John W Wages, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 4100 Duval Rd, Bldg Iii Suite 200, Austin, TX 78759 Phone: 512-485-7200 Fax: 512-485-7224 | |
Allison Rae Losey, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3705 Medical Pkwy, Suite 570, Austin, TX 78705 Phone: 512-454-2554 | |
Dr. James Patrick Fogarty Jr., M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 8140 N Mopac Expy Ste 3-210, Austin, TX 78759 Phone: 512-343-2292 | |
Vijay K. Ravula, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 919 E 32nd St, Austin, TX 78705 Phone: 512-476-7111 | |
Gary L. Mihm, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 919 E 32nd St, Austin, TX 78705 Phone: 512-476-7111 | |
Todd Paricio, M.D Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3801 N Lamar Blvd, Austin, TX 78756 Phone: 512-407-8444 Fax: 512-407-8097 | |
Dr. Rebecca R Porras, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 3705 Medical Pkwy, Suite 570, Austin, TX 78705 Phone: 512-454-2454 Fax: 512-454-1532 |